未知生产厂商
PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) is a gene that helps regulate levels of 'bad' cholesterol (LDL cholesterol) in the blood. It is the target of several treatments used to reduce the risk of heart attack or stroke. Naturally occurring loss-of-function variants of PCSK9 that switch the gene off have been shown to reduce the risk of coronary heart disease.
PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) is a gene that helps regulate levels of 'bad' cholesterol (LDL cholesterol) in the blood. It is the target of several treatments used to reduce the risk of heart attack or stroke. Naturally occurring loss-of-function variants of PCSK9 that switch the gene off have been shown to reduce the risk of coronary heart disease.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。